This is a standard Form 3 filing for a newly appointed insider at a SPAC. No trading signal. Monitor for any subsequent Form 4 filings or business combination announcements from the SPAC.
Price Chart
Executive Summary
Benjamin L. Palleiko filed an initial statement of beneficial ownership (Form 3) with the SEC, disclosing his holdings in Frazier Life Sciences Acquisition Corp. II, a blank-check SPAC. He reports indirect beneficial ownership of 87,188 Class A ordinary shares through GTBAP Limited Partnership and 30,000 Class A ordinary shares held directly. This is a routine insider filing with no material financial impact.
Key Facts
- Benjamin L. Palleiko filed Form 3 as an officer/director of Frazier Life Sciences Acquisition Corp. II
- Reports 87,188 Class A ordinary shares held indirectly via GTBAP Limited Partnership
- Reports 30,000 Class A ordinary shares held directly
- Also holds Class B ordinary shares (amount not specified) that convert to Class A upon business combination
- Filing is a routine initial ownership disclosure with no transaction or corporate event
Financial Impact
No financial impact — routine ownership disclosure
Risk Factors
- No material risks identified from this filing
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-420796 |
| Document: 0001193125-26-420796-index-headers.html | 0001193125-26-420796 |
| Document: 0001193125-26-420796-index.html | 0001193125-26-420796 |
| Document: 0001193125-26-420796.txt | 0001193125-26-420796 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $10.30 | awaiting T+5 | — | $10.28 (−0.19%) |
Oct 22, 2026 4d ago | SC 13G | $10.30 | awaiting T+5 | — | $10.28 (−0.19%) |
Oct 21, 2026 5d ago | SC 13D | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.28 (+0.10%) |
Oct 16, 2026 10d ago | SC 13G | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 15, 2026 11d ago | Insider Buy | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 15, 2026 11d ago | 8-K | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.28 (−0.68%) |
Oct 14, 2026 12d ago | 424B4 | $10.49 $10.27 | ▼ −2.10% | ▼ −1.08% | $10.28 (−2.00%) |
Oct 14, 2026 13d ago | EFFECT | $10.29 $10.30 | ▲ +0.10% | ▼ −0.36% | $10.28 (−0.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers